Activation of 5-HT1A autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo

Neuropharmacology

Volumn 44, Issue 2, 2003, Pages 206-213

  Yoshitake, T ^a   Yoshitake, S ^a   Yamaguchi, M ^b   Ogren S O ^a   Kehr, J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

5 HT1A receptor; Dorsal raphe nucleus; Galanin; Hippocampus; Microdialysis; Receptor receptor interaction; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; GALANIN; GALANIN RECEPTOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DOSE TIME EFFECT RELATION; DOWN REGULATION; DRUG EFFECT; DRUG INFUSION; DRUG POTENCY; DRUG RECEPTOR BINDING; HIPPOCAMPUS; INHIBITION KINETICS; INJECTION; MALE; MEASUREMENT; MICRODIALYSIS; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SENSITIZATION; SEROTONIN RELEASE; STIMULATION; WAKEFULNESS;

EID: 0037293040     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00373-8     Document Type: Article

References (44)

1. Artigas F., Perez V., Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Archives of General Psychiatry. 51:1994;248-251.
2. Bellido I., Diaz-Cabiale Z., Jimenez-Vasquez P.A., Andbjer B., Mathe A.A., Fuxe K. Increased density of galanin binding sites in the dorsal raphe in a genetic rat model of depression. Neuroscience Letters. 317:2002;101-105.
3. Branchek T.A., Gustafson E.L., Walker M.W., Forray C., Smith K.E., Gerald C., Durkin M.M. Autoradiographic localization of the GALR2 receptor subtype in the rat CNS. Soc Neurosci Abstr. 23:1997;965.
4. Branchek T.A., Smith K.E., Gerald C., Walker M.W. Galanin receptor subtypes. Trends in Pharmacological Sciences. 21:2000;109-116.
5. Crawley J.N. Minireview: Galanin-acetylcholine interactions: Relevance to memory and Alzheimer's disease. Life Sciences. 58:1996;2186-2199.
6. Crawley J.N. The role of galanin in feeding behavior. Neuropeptides. 33:1999;369-375.
7. 1A receptor antagonist, WAY-100635. European Journal of Pharmacology. 281:1995;81-88.
8. Frishman W.H. Pindolol: a new adrenoceptor antagonist with partial agonist activity. New England Journal of Medicine. 308:1983;940-944.
9. Fuxe K., Agnati L.F., von Euler G., Lundgren K., Zoli M., Bjelke B., Eneroth P., Ögren S.O. Galanin/5-HT receptor interactions. A new integrative mechanism in the control of 5-HT neurotransmission in the CNS. Paoletti R., Vanhoutte P.M. Serotonin: From Cell Biology to Pharmacology and Therapeutics. 1990;169-185 Kluwer Academic, Dordrecht.
10. Fuxe K., Hedlund P., von Euler G., Lundgren K., Martire M., Ögren S.O., Eneroth P., Agnati L.F. Galanin/5-HT interactions in the rat central nervous system: Relevance for depression. Hökfelt T., Bartfai T., Jacobowitz D., Ottosson D. Galanin: a new multifunctional peptide in the neuroendocrine system. 1991;221-235 MacMillan Press, London.
11. Fuxe K., Ögren S.O., Jansson A., Cintra A., Härfstrand A., Agnati L.F. Intraventricular injections of galanin reduces 5-HT metabolism in the ventral limbic cortex, the hippocampal formation and the fronto-parietal cortex of the male rat. Acta Physiologica Scandinavica. 133:1988;579-581.
12. 1A receptors in the rat ventral limbic cortex. Neuroscience Letters. 85:1988;163-167.
13. 1A receptor interactions as an integrative mechanism in 5-HT neurotransmission in the brain. Annals of the New York Academy of Sciences. 780:1996;193-212.
14. Hedlund P., von Euler G., Fuxe K. Activation of 5-hydroxytryptamine 1A receptors increases the affinity of galanin receptors in di- and telencephalic areas of the rat. Brain Research. 560:1991;251-259.
15. Holmes P.V., Blanchard D.C., Blanchard R.J., Brady L.S., Crawley J.N. Chronic social stress increases levels of preprogalanin mRNA in the rat locus coeruleus. Pharmacology Biochemistry and Behavior. 50:1995;655-660.
16. Hökfelt T., Bartfai T., Crawley J. Galanin: Basic Research Discoveries and Therapeutic Implications, vol. 863. 1998a;Annals of the New York Academy of Sciences, The New York Academy of Sciences, USA.
17. Hökfelt T., Xu Z.Q., Shi T.J., Holmberg K., Zhang X. Galanin in ascending systems, Focus on coexistence with 5-hydroxytryptamine and noradrenaline. Annals of the New York Academy of Sciences. 863:1998;252-263.
18. Ishida J., Yoshitake T., Fujino K., Kawano K., Kehr J., Yamaguchi M. Fluorescence detection. Analytica Chimica Acta. 365:1998;227-232.
19. Johansson L., Sohn D., Thorberg S.O., Jackson D.M., Kelder D., Larsson L.G., Renyi L., Ross S.B., Wallsten C., Eriksson H., Hu P.S., Jerning E., Mohell N., Westlinddanielsson A. The pharmacological characterization of a novel selective 5-hydroxytryptamine(1A) receptor antagonist, NAD-299. Journal of Pharmacology and Experimental Therapeutics. 283:1997;216-225.
20. Kehr J., Yoshitake T., Wang F-H., Razani H., Gimenez-Llort L., Jansson A., Yamaguchi M., Ögren S.O. Galanin is a potent in vivo modulator of mesencephalic serotonergic neurotransmission. Neurosychophamacology. 27:2002;341-356.
21. Melander T., Hökfelt T., Rökaeus Å. Distribution of galanin-like immunoreactivity in the rat central nervous system. Journal of Comparative Neurology. 248:1986;475-517.
22. 1A receptor-mediated behavioural response in the rat. European Journal of Neuroscience. 10:1998;1230-1240.
23. Moller C., Sommer W., Thorsell A., Heilig M. Anxiogenic-like action of galanin after intra-amygdala administration in the rat. Neuropsychopharmacology. 21:1999;507-512.
24. O'Donnell D., Ahmad S., Wahlestedt C., Walker P. Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1. Journal of Comparative Neurology. 409:1999;469-481.
25. Ögren S.O., Schött P.A., Kehr J., Yoshitake T., Misane I., Mannström P., Sandin J. Modulation of acetylcholine and serotonin transmission by galanin: Relationship to spatial and aversive learning. Annals of the New York Academy of Sciences. 863:1998;342-363.
26. Ögren S.O., Schött P.A., Kehr J., Misane I., Razani H. Galanin and learning. Brain Research. 848:1999;174-182.
27. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1997;Academic Press, Australia.
28. 1A receptors on dorsal raphe neurons of the adult rat. Journal of Physiology. 469:1993;387-405.
29. Pineyro G., Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacological Reviews. 51:1999;533-591.
30. Priestley J.V., Wotherspoon G., Savery D., Averill S., Rattray M. A combined in situ hybridization and immunofluorescence procedure allowing visualisation of peptide mRNA and serotonin in single sections. Journal of Neuroscience Methods. 48:1993;99-110.
31. 1A receptors in the dorsal raphe of the rat. Neuroreport. 11:2000;3943-3948.
32. 1A receptor mediated function in the rat. Neuroscience Letters. 299:2001;145-149.
33. Riad M., Watkins K., Doucet E., Hamon M., Descarries L. Agonist-induced internalization of serotonin-1A receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). Journal of Neuroscience. 21:2001;8378-8386.
34. Rökaeus Å. Galanin: a newly isolated biologically active neuropeptide. Trends in Neurosciences. 10:1987;158-164.
35. 1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. British Journal of Pharmacology 96. 96:1989;283-290.
36. Sharp T., Bramwell S.R., Hjorth S., Grahame-Smith D.G. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by brain microdialysis. British Journal of Pharmacology. 98:1989;989-997.
37. Skofitsch G., Jacobowitz D.M. Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides. 6:1985;509-546.
38. Skofitsch G., Jacobowitz D.M. Quantitative distribution of galanin-like immunoreactivity in the rat central nervous system. Peptides. 7:1986;609-613.
39. 1A selective agonists. European Journal of Pharmacology. 128:1986;295-298.
40. Tatemoto K., Rökaeus Å., Jörnvall H., McDonald T.J., Mutt V. Galanin: a novel biologically active peptide from porcine intestine. FEBS Letters. 164:1983;124-128.
41. Xu Z.Q., Zhang X., Pieribone V.A., Grillner S., Hokfelt T. Galanin-5-hydroxytryptamine interactions: electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors. Neuroscience. 87:1998;79-94.
42. Yu H., Lewander T. Pharmacokinetic and pharmacodynamic studies of (R)-8-hydroxy-2-(di-n-propylamino)tetralin in the rat. European Neuropsychopharmacology. 7:1997;165-172.
43. Wrenn C.C., Crawley J.N. Pharmacological evidence supporting a role for galanin in cognition and affect. Progress in Neuropsychopharmacology and Biological Psychiatry. 25:2001;283-299.
44. Zachariou V., Thome J., Parikh K., Picciotto M.R. Upregulation of galanin binding sites and GalR1 mRNA levels in the mouse locus coeruleus following chronic morphine treatments and precipitated morphine withdrawal. Neuropsychopharmacology. 23:2000;127-137.